Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Boceprevir for chronic HCV genotype 1 infection.

× No keyword cloud information.

7 in total

1. Direct-acting antiviral agents in patients with hepatitis C cirrhosis.

Authors: Gene Y Im; Douglas T Dieterich
Journal: Gastroenterol Hepatol (N Y) Date: 2012-11

Review 2. Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.

Authors: Kenneth E Sherman
Journal: Clin Infect Dis Date: 2012-07-26 Impact factor: 9.079

3. Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.

Authors: Sarah Kattakuzhy; Eleanor Wilson; Sreetha Sidharthan; Zayani Sims; Mary McLaughlin; Angie Price; Rachel Silk; Chloe Gross; Elizabeth Akoth; Maryellen McManus; Benjamin Emmanuel; Shikha Shrivastava; Lydia Tang; Amy Nelson; Gebeyehu Teferi; Jose Chavez; Brian Lam; Hongmei Mo; Anuoluwapo Osinusi; Michael A Polis; Henry Masur; Anita Kohli; Shyamasundaran Kottilil
Journal: Clin Infect Dis Date: 2015-10-26 Impact factor: 9.079

4. Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy.

Authors: Ahmed El-Shamy; Ikuo Shoji; Soo-Ryang Kim; Yoshihiro Ide; Susumu Imoto; Lin Deng; Seitetsu Yoon; Takashi Fujisawa; Satoshi Tani; Yoshihiko Yano; Yasushi Seo; Takeshi Azuma; Hak Hotta
Journal: PLoS One Date: 2012-02-02 Impact factor: 3.240

5. NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.

Authors: Ahmed El-Shamy; Ikuo Shoji; Wafaa El-Akel; Shymaa E Bilasy; Lin Deng; Maissa El-Raziky; Da-peng Jiang; Gamal Esmat; Hak Hotta
Journal: J Clin Microbiol Date: 2012-09-19 Impact factor: 5.948

Review 6. Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.

Authors: Ahmed El-Shamy; Hak Hotta
Journal: World J Gastroenterol Date: 2014-06-28 Impact factor: 5.742

7. Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs.

Authors: Kathleen B Mihalik; Dino A Feigelstock
Journal: PLoS One Date: 2013-09-05 Impact factor: 3.240

7 in total